Dr. Sherry Sussman, MD (she/her) is an Endocrinologist in Smithtown, NY with over 16 years of experience. What is your opinion of Dr. Sherry Sussman, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Sherry Sussman, MD has received over $148,600 which includes payments from the following companies:
$54,963.03 from Janssen Pharmaceuticals, Inc
$20,911.42 from Amarin Pharma Inc.
$18,505.49 from Novo Nordisk Inc
$18,331.56 from sanofi-aventis U.S. LLC
$11,731.28 from AstraZeneca Pharmaceuticals LP
$4,112.00 from Senseonics, Incorporated
$2,201.12 from LILLY USA, LLC
$1,436.55 from Amgen Inc.
$1,425.67 from Novo Nordisk AS
$1,420.61 from Boehringer Ingelheim Pharmaceuticals, Inc.
$1,128.54 from INSULET CORPORATION
$1,047.93 from Medtronic MiniMed, Inc.
$972.70 from MannKind Corporation
$959.90 from Merck Sharp & Dohme Corporation
$936.96 from AbbVie, Inc.
$708.46 from Shire North American Group Inc
$704.00 from Valeritas, Inc.
$544.83 from Abbott Laboratories
$517.98 from Kowa Pharmaceuticals America, Inc.
$436.67 from GlaxoSmithKline, LLC.
Payments received by Dr. Sherry Sussman, MD were from the following categories:
$106,118.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!